Human cytidine deaminase APOBEC3H restricts HIV-1 replication - Wikidata - awgldk - TriplyDB

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

http://www.wikidata.org/entity/Q24653682

about

Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1 Antiretroelement activity of APOBEC3H was lost twice in recent human evolution Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1 The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors HIV-1 Vif, APOBEC, and intrinsic immunity Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all The APOBEC3 family of retroelement restriction factors Suppression of APOBEC3-mediated restriction of HIV-1 by Vif Structural Insights into HIV-1 Vif-APOBEC3F Interaction SIV replication in human cells Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.Demonstration of a novel HIV-1 restriction phenotype from a human T cell line The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Functional annotation of proteome encoded by human chromosome 22.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome.Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.Alcohol enhances HIV infection of cord blood monocyte-derived macrophages N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.Morphine suppresses IFN signaling pathway and enhances AIDS virus infection.Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells.Select host restriction factors are associated with HIV persistence during antiretroviral therapy.Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities.The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans.

P2860

Q21144862-BADEB8AE-E61E-4573-8F56-1A37FE35FAE4 Q24297395-397623CC-EF1A-4366-89C5-D95D0192B934 Q24310242-D52B7A92-66FB-47B8-BB24-A10D0D804AAD Q24311460-55B0EFD2-9B19-47A3-9360-DB38927886F0 Q24317568-C9A53594-4E29-4DDB-AC28-8EF40FA02DB0 Q24596322-DB503B14-A69E-40E0-87DE-A51F3C512AAA Q24619114-5DED8287-396B-40EE-9DDA-E8FED1111C9F Q24647833-74994F79-B6F1-4F10-9D4C-E34A75C78B02 Q24655418-9E5D0F2D-28AD-4A7B-A26F-4CB58C0F4316 Q24656551-B6766E2C-19DF-4171-888A-23632E5B69C3 Q26823568-0C8BD650-55D7-48BF-BD48-53CAED342796 Q26862780-26B02EB6-41E9-4221-9B15-39117BFD4728 Q27025150-7A55694F-CF90-4787-9CE2-DD71144D4996 Q27321018-58225868-4A93-4249-A4FF-ADF11BE0452D Q30417737-C80BE882-1605-4A53-AC77-D197CFA382E2 Q31078477-28BC4004-7856-4C45-BB8D-B6807DAF170F Q33349452-1E3F295D-32BE-4DC2-8E5B-23049C2C1404 Q33355942-AFFDCDAA-1B7F-402A-81C0-83BCBEC1B09E Q33385376-F987671D-F172-4396-B691-6FF59FB94084 Q33654949-2233D638-CC6E-411D-BA3E-EF4860AE5018 Q33761772-AA690D43-2C1B-4465-99D5-6EC5FC92EA98 Q33815187-9E416583-FCC9-4D63-9AFE-030DADC9459C Q33877364-173A3F69-3C51-4557-A49F-015957101D3C Q33925040-24FA037D-4217-41B6-A77F-C3457C5E4923 Q34020228-007D8F43-1C1E-428A-B5A5-57505D0FCE4D Q34045987-A6FD2798-63D0-4C7B-8C0F-6E46C5D3391F Q34055413-1C371D4A-60E8-4B3A-B7CA-BFBE6BB605C8 Q34129449-84FBCBD6-8D42-40E0-A613-A47F7F701C8E Q34166447-54E1F991-0C00-4EEF-BBF2-8A087DEC79C6 Q34168153-5AB076BD-5EFA-4DC8-945D-74E08F00D337 Q34179686-934F3E53-01D2-4FFB-AD64-DC4AB5FFCA81 Q34612416-09E83202-3428-4EFE-95AF-40CBA0A1F5DB Q34742607-1D2CBF63-C977-41C3-BA99-5E8C15B27E80 Q35068754-31C2ECC8-07FD-4696-9195-7BE44E3B96BA Q35076674-4B48EEE7-0D6D-4C89-BDB1-B310622BB6AE Q35271996-7B80C177-5AD6-4B14-B2CE-E51ABF747017 Q35531709-1727F16B-BAD8-4EAB-9BAD-EDC934C525EB Q35627352-F555665A-B1BD-419D-ADB0-9E34710A22D6 Q35666084-FEB16225-B81C-4530-8B12-5DEDE42F8EFB Q36031782-2780CDD8-E2C6-49FA-8610-F734656A997B

P2860

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

http://www.wikidata.org/entity/Q24653682

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@ast

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@en

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@nl

type

label

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@ast

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@en

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@nl

prefLabel

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@ast

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@en

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@nl

P1433

Q24653682-A703F0DA-F9EF-4958-8A5D-2DA705F2E9C4

P1476

Q24653682-DFC9EC90-DAF8-4398-92E3-A1DA8EB598C7

P2093

Q24653682-319FE844-CC0D-4CE1-AC26-DEE791329396

Q24653682-600EC7E2-FD03-4217-BCED-88E1E38923DC

Q24653682-8C5FD9EA-17BF-401A-ADE4-2D5C3F0399BD

Q24653682-95F3EDE8-415C-4659-A621-76D9D4A7E130

Q24653682-E0DC40C4-2C4C-425A-B9EE-862DC6DC3649

P2860

Q24653682-086AFB20-7130-4638-92CD-64913E672555

Q24653682-09F36940-2BF8-4F85-9BF0-B639507C55B1

Q24653682-0F3E31BD-A800-40F4-86C6-C03D2D8391D0

Q24653682-189E2768-8E5C-43AB-8760-26C42F1F391C

Q24653682-1A0C8DEF-7703-42BC-A6EC-25C6A401309B

Q24653682-1D3A94B2-B423-4BBD-AC94-51DABA6A6B00

Q24653682-1F41B838-3301-4D27-84A8-A4DEB4C46363

Q24653682-2E07B4CB-BB22-4A14-9A2E-FB593797AACD

Q24653682-3FCE386D-041C-44A2-9A3E-9F0E9A43674D

Q24653682-4477E560-4D69-4C75-8429-9AFDD7325941

P304

Q24653682-F5F21038-4AFB-430C-A4D7-6B94F6FA66D3

P31

Q24653682-9F089344-1EF6-4F60-B8B4-D8DFC30345DB

P3181

Q24653682-B90DB5CA-BEC0-4E47-B45F-D49814C79F4B

P356

Q24653682-76164ED4-8CBD-41B7-AD84-747D280BA097

P407

Q24653682-B124246E-A8AA-433B-8A72-98847FE85768

P433

Q24653682-0BFD70D0-FBBF-407B-B62F-F30D3B887904

P478

Q24653682-A2F059EE-BCD4-41BD-BFAE-1D9981C2F636

P50

Q24653682-597082E7-42D6-4DBE-B5A9-E3E2AFE57F33

P577

Q24653682-849458EE-BB9F-4BC9-9A24-9E9E4E54DECE

P698

Q24653682-8CD20640-6F9E-4A26-B900-B994BE6ED18F

P921

Q24653682-7AD1FB65-4BC1-4F5B-B8E1-97A880E97441

P932

Q24653682-CD4F1D0A-ED26-4CF6-BF80-8CC13E5D5D66

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

@en

P2093

Lai Mun Siew

http://www.w3.org/2001/XMLSchema#string

Russell Lampen

http://www.w3.org/2001/XMLSchema#string

Yanxing Han

http://www.w3.org/2001/XMLSchema#string

Ying Dang

http://www.w3.org/2001/XMLSchema#string

Yong-Hui Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Population stratification of a common APOBEC gene deletion polymorphism

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration

P304

11606-11614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3626183

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M707586200

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18299330

http://www.w3.org/2001/XMLSchema#string

P921

P932

2430661

http://www.w3.org/2001/XMLSchema#string